Intermittent fasting in subjects with insulin-treated type 2 diabetes mellitus - Interfast 2

Medizinische Universität Graz0 个研究点目标入组 46 人开始时间: 2019年9月3日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Type 2 Diabetes Mellitus, Age between 18 and 75 years, both inclusive, Glycated hemoglobin levels (HbA1c =7.5%) (Point of care measurements or HbA1c measurement within the last 4 weeks are acceptable), Total daily insulin dose = 0.3 IU/Kg, Stable body weight for preceding 3 months (< 3kg increase or decrease), Able and willing to safely comply with study procedures, Be able to attend the study site and willing to participate in necessary protocols, Be willing to undertake the durations of fasting required by the study

•Known malignancy, Pregnancy or intention of becoming pregnant; breastfeeding, History of any chronic disease process that could interfere with interpretation of study results, New hormonal supplementation or new contraceptive hormonal medication for less than 2 months, Type 1 Diabetes Mellitus or other forms of diabetes mellitus, Acute or chronic inflammatory disorder, Alcohol abuse (more than 15 drinks / week), Currently perform overnight shift work, Intake of illicit substances

发起方